| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.54 | 0.0007 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |